/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Sherry A. Weppler

Acuitas Therapeutics (Canada)(CA)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

31

Papers

1.0K

Citations

11

h-index

11

i10-index

Sherry A. Weppler is an academic researcher from Acuitas Therapeutics (Canada). The author has contributed to research in topics: Autophagy in Disease and Therapy & Histone Deacetylase Inhibitors Research & PARP inhibition in cancer therapy. The author has an h-index of 11, co-authored 27 publications.

ORCID: 0009-0009-9335-3174

Research Topics

Autophagy in Disease and Therapy Histone Deacetylase Inhibitors Research PARP inhibition in cancer therapy PI3K/AKT/mTOR signaling in cancer Calcium signaling and nucleotide metabolism

Papers by this author

works

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

2011 · BMC Cancer · 28 citations

https://doi.org/10.1186/1471-2407-11-420

Wieslawa H. Dragowska Sherry A. Weppler Mohammed A. Qadir Ling Yan Wong

Research topics

topics

Autophagy in Disease and Therapy

Histone Deacetylase Inhibitors Research

PARP inhibition in cancer therapy

PI3K/AKT/mTOR signaling in cancer

Calcium signaling and nucleotide metabolism

Chat about Author

Papers

Chat

Click to start Chat